Reports for AA PHARMA INC
Company Name AA PHARMA INC |
||
|---|---|---|
Totals |
||
Shortage reports |
446 |
|
| Actual shortage: | 21 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (1%) | |
| Resolved: | 419 (94%) | |
Discontinuation Reports |
63 |
|
| To be discontinued: | 9 (14%) | |
| Discontinued: | 52 (83%) | |
| Reversed: | 2 (3%) | |
Late reports |
30 (6%) |
|
Overdue reports |
20 (67%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AA-THEO LA | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-11-07 | 2024-12-02 | 242159 |
| ACETAZOLAMIDE | 250MG | TABLET | Resolved | 2017-07-07 | 2017-07-13 | 14896 |
| ACETAZOLAMIDE | 250MG | TABLET | Resolved | 2018-01-09 | 2018-04-23 | 35352 |
| ACETAZOLAMIDE | 250MG | TABLET | Resolved | 2023-02-03 | 2023-04-05 | 183593 |
| ACETAZOLAMIDE | 250MG | TABLET | Resolved | 2024-04-24 | 2024-05-30 | 226024 |
| ACETAZOLAMIDE | 250MG | TABLET | Resolved | 2024-09-04 | 2024-12-02 | 236684 |
| ACETAZOLAMIDE | 250MG | TABLET | Resolved | 2025-03-12 | 2025-04-16 | 252435 |
| APO CIMETIDINE TAB 300MG | 300MG | TABLET | Resolved | 2017-03-10 | 2017-06-08 | 93 |
| APO CIMETIDINE TAB 300MG | 300MG | TABLET | Resolved | 2017-06-28 | 2017-08-21 | 14163 |
| APO CIMETIDINE TAB 300MG | 300MG | TABLET | Resolved | 2018-03-20 | 2018-07-03 | 43505 |
| APO CIMETIDINE TAB 400MG | 400MG | TABLET | Actual shortage | 2017-03-10 | 2017-10-05 | 99 |
| APO CIMETIDINE TAB 600MG | 600MG | TABLET | Actual shortage | 2017-03-10 | 2018-09-08 | 104 |
| APO DIAZEPAM TAB 5MG | 5MG | TABLET | Resolved | 2017-05-02 | 2017-06-13 | 8587 |
| APO DIAZEPAM TAB 5MG | 5MG | TABLET | Avoided shortage | 2017-09-04 | 2017-10-31 | 20866 |
| APO DIAZEPAM TAB 5MG | 5MG | TABLET | Resolved | 2018-07-04 | 2018-09-09 | 54174 |
| APO DILTIAZ TAB 30MG | 30MG | TABLET | Resolved | 2017-07-11 | 2018-09-28 | 15252 |
| APO DILTIAZ TAB 60MG | 60MG | TABLET | Resolved | 2017-05-24 | 2018-10-17 | 11066 |
| APO FOLIC ACID TAB 5MG | 5MG | TABLET | Resolved | 2018-02-13 | 2019-01-16 | 39653 |
| APO HYDROXYZINE CAP 10MG | 10MG | CAPSULE | Resolved | 2017-05-24 | 2017-08-10 | 11069 |
| APO HYDROXYZINE CAP 25MG | 25MG | CAPSULE | Resolved | 2017-06-08 | 2017-09-22 | 12289 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PHENYTOIN SODIUM | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-12-28 | 60687 |
| AVENTYL | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2022-01-27 | 65435 |
| CHLORAX | 2.5MG 5MG | CAPSULE | Discontinued | 2022-01-20 | 2022-01-21 | 153244 |
| CHLORDIAZEPOXIDE | 10MG | CAPSULE | Discontinued | 2024-06-26 | 2024-06-27 | 231340 |
| CHLORDIAZEPOXIDE | 5MG | CAPSULE | Discontinued | 2024-06-26 | 2024-06-27 | 231343 |
| CHLORDIAZEPOXIDE | 25MG | CAPSULE | To be discontinued | 2024-06-26 | 2024-06-26 | 231348 |
| DIFLUNISAL | 250MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108364 |
| DIFLUNISAL | 500MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108367 |
| DOXEPIN | 50MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65463 |
| ELAVIL | 50MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247839 |
| ELAVIL | 50MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247836 |
| ELAVIL | 25MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247833 |
| ELAVIL | 25MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247830 |
| ELAVIL | 10MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247827 |
| ELAVIL | 10MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247824 |
| ELAVIL | 75MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247842 |
| ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2022-04-01 | 2022-04-02 | 157808 |
| ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2017-03-28 | 2017-03-28 | 4584 |
| ERYTHRO-ES | Discontinued | 2018-12-07 | 2018-12-08 | 68904 | ||
| ERYTHRO-ES | 600MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121825 |